SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 8-K - Current report:
SEC Accession No. 0001213900-24-014582
Filing Date
2024-02-15
Accepted
2024-02-15 16:30:52
Documents
14
Period of Report
2024-02-09
Items
Item 2.04: Triggering Events That Accelerate or Increase a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement

Document Format Files

Seq Description Document Type Size
1 FORM 8-K ea193895-8k_aditxt.htm   iXBRL 8-K 28841
  Complete submission text file 0001213900-24-014582.txt   204108

Data Files

Seq Description Document Type Size
2 XBRL SCHEMA FILE adtx-20240209.xsd EX-101.SCH 3009
3 XBRL LABEL FILE adtx-20240209_lab.xml EX-101.LAB 34240
4 XBRL PRESENTATION FILE adtx-20240209_pre.xml EX-101.PRE 22355
15 EXTRACTED XBRL INSTANCE DOCUMENT ea193895-8k_aditxt_htm.xml XML 3707
Mailing Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219
Business Address 737 N. FIFTH STREET, SUITE 200 RICHMOND VA 23219 909-488-0844
Aditxt, Inc. (Filer) CIK: 0001726711 (see all company filings)

IRS No.: 823204328 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-39336 | Film No.: 24644280
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)